Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,806 JPY | +2.37% | -2.20% | 0.00% |
May. 06 | Calliditas Therapeutics' Potential Head and Neck Cancer Treatment Meets Secondary Endpoints | MT |
May. 06 | UK Tribunal Greenlights GBP790 Million Lawsuit vs Prysmian, Nexans, NKT | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 2.11B | |
+16.24% | 335B | |
-8.24% | 67.78B | |
+3.27% | 29.91B | |
+24.22% | 23.96B | |
+12.07% | 14.3B | |
+15.68% | 10.15B | |
+23.15% | 9.57B | |
-5.07% | 6.58B | |
+5.22% | 4.82B |
- Stock Market
- Equities
- 141A Stock
- News Trial Holdings Inc.
- NeuroBo Begins Dosing in Phase 1 Study of Obesity Treatment; Shares Rise